Fatty Acid/Fish Oil Supplement

Verify with FDA CVM →

122 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
122
Total Reports
3
Deaths Reported
250.0%
Death Rate

Active Ingredients

Fatty Acid/Fish Oil Supplement

Administration Routes

OralUnknown

Species Affected

Dog 120
Cat 2

Most Affected Breeds

Retriever - Labrador 16
Retriever - Golden 9
Shepherd Dog - German 6
Shih Tzu 5
Pit Bull 5
Terrier - Yorkshire 4
Boxer (German Boxer) 4
Doberman Pinscher 4
Collie - Border 4
Retriever (unspecified) 3

Most Reported Reactions

Emesis 29
Vomiting 22
Lethargy (see also Central nervous system depression in 'Neurological') 21
Lack of efficacy - NOS 14
Diarrhoea 11
Other abnormal test result NOS 7
Seizure NOS 6
Pruritus 4
Decreased appetite 4
Elevated alanine aminotransferase (ALT) 4
Ataxia 4
Behavioural disorder NOS 4

Outcome Breakdown

Recovered/Normal
57 (46.7%)
Outcome Unknown
28 (23.0%)
Ongoing
21 (17.2%)
Recovered with Sequela
13 (10.7%)
Died
2 (1.6%)
Euthanized
1 (0.8%)

Data Summary

Metric Value
Total adverse event reports 122
Reports involving death 3
Case-fatality rate (reported events) 250.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fatty Acid/Fish Oil Supplement Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 122 adverse event reports referencing Fatty Acid/Fish Oil Supplement, including 3 reports in which the animal died — a 250.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Fatty Acid/Fish Oil Supplement. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fatty Acid/Fish Oil Supplement reports are Dog (120 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (16), Retriever - Golden (9), Shepherd Dog - German (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fatty Acid/Fish Oil Supplement are Emesis (29), Vomiting (22), Lethargy (see also Central nervous system depression in 'Neurological') (21), Lack of efficacy - NOS (14). Of the 122 reports with a coded outcome, Recovered/Normal is the leading category at 46.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fatty Acid/Fish Oil Supplement.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial